Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Beta Bionics Inc (NASDAQ: BBNX) closed at $15.96 down -3.30% from its previous closing price of $16.5. In other words, the price has decreased by -$3.30 from its previous closing price. On the day, 0.65 million shares were traded. BBNX stock price reached its highest trading level at $16.6 during the session, while it also had its lowest trading level at $15.83.
Ratios:
For a deeper understanding of Beta Bionics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.83 and its Current Ratio is at 10.64. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Goldman Upgraded its Neutral to Buy on October 01, 2025, while the target price for the stock was maintained at $26.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 06 ’26 when Mensinger Mike sold 2,200 shares for $30.10 per share. The transaction valued at 66,221 led to the insider holds 80,752 shares of the business.
Mensinger Mike sold 7,800 shares of BBNX for $230,950 on Jan 02 ’26. The Chief Product Officer now owns 82,952 shares after completing the transaction at $29.61 per share. On Jan 02 ’26, another insider, Feider Stephen, who serves as the Chief Financial Officer of the company, sold 20,000 shares for $29.53 each. As a result, the insider received 590,680 and left with 42,614 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBNX now has a Market Capitalization of 702633152 and an Enterprise Value of 481633120. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.93 while its Price-to-Book (P/B) ratio in mrq is 2.38. Its current Enterprise Value per Revenue stands at 5.438 whereas that against EBITDA is -7.154.
Stock Price History:
The Beta on a monthly basis for BBNX is 5.82, which has changed by -0.3245874 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, BBNX has reached a high of $32.71, while it has fallen to a 52-week low of $8.89. The 50-Day Moving Average of the stock is -41.61%, while the 200-Day Moving Average is calculated to be -19.93%.
Shares Statistics:
For the past three months, BBNX has traded an average of 1.06M shares per day and 2268980 over the past ten days. A total of 43.99M shares are outstanding, with a floating share count of 33.41M. Insiders hold about 24.12% of the company’s shares, while institutions hold 95.32% stake in the company. Shares short for BBNX as of 1767139200 were 7301052 with a Short Ratio of 6.88, compared to 1764288000 on 3860691. Therefore, it implies a Short% of Shares Outstanding of 7301052 and a Short% of Float of 18.69.
